Fabtech Technologies Limited (NSEI: FABTECH)
Health Care · Life Sciences Tools & Services · IN
Rs142.01
-2.62% today · -22.1% 1Y
Fabtech Technologies Limited (NSEI: FABTECH) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $65.56M.
Over the last twelve months the share price has lost 22.1%, trading between 132.70 and 262.80.
Tweenvest scores Fabtech Technologies Limited across four factors: quality 72/100, value 52/100, growth 85/100, dividend 91/100. Its strongest factor is dividend.
FABTECH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $65.56M
- Revenue (TTM)
- $44.18M
- P/E
- 12.05
- EPS
- 11.78
- Dividend yield
- 0.42%
- Beta (5Y)
- —
- 52-week high
- Rs262.80
- 52-week low
- Rs132.70
- Avg volume (3M)
- —
- Shares outstanding
- 44.45M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MindWalk Holdings Corp.NasdaqCM: HYFT | $70.67M | $1.43 | -4.67% |
| Xlife Sciences AGSWX: XLS | $68.15M | CHF9.80 | -4.85% |
| Champions Oncology, Inc.NasdaqCM: CSBR | $67.92M | $4.98 | +2.05% |
| Immuno-Biological Laboratories Co., Ltd.TSE: 4570 | $67.61M | ¥1,145.00 | -5.37% |
| Influx Healthtech LimitedNSEI: INFLUX | $61.55M | Rs256.00 | -9.04% |
| Circle8 Group, Inc.NasdaqGM: CIRC | $58.40M | $0.45 | -12.63% |
| Pangaea Oncology, S.A.BME: PANG | $57.80M | €1.43 | 0.00% |
| Carna Biosciences, Inc.TSE: 4572 | $55.80M | ¥413.00 | -9.23% |
Figures last refreshed Oct 4, 2026.